Neurocrine Biosciences Inc
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · San Diego, CA
NBIX chart
What traders are saying about $NBIX
Latest postsNeurocrine Biosciences Inc news
- Amneal Pharmaceuticals (AMRX) Earnings Expected to Grow: Should You Buy?
Yahoo Finance ·
- Neurocrine Biosciences (NBIX) Earnings Expected to Grow: Should You Buy?
Yahoo Finance ·
- Neurocrine Biosciences Presents New Analysis Establishing Benchmark for Clinically Meaningful Change in Overall Health Reported by Patients with Tardive Dyskinesia
Yahoo Finance ·
- Expert Backing For VYKAT XR Could Matter For Neurocrine Biosciences Stock
Simply Wall Street ·
- Neurocrine Biosciences, Inc. (NBIX) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Where Will Neurocrine Biosciences Be in 5 Years?
fool.com ·
- Neurocrine Biosciences, Inc. (NBIX) stock price, news, quote and history
Yahoo Finance Australia ·
- Neurocrine Biosciences (NBIX) Could Be 31% Undervalued Following VYKAT XR And Alzheimer’s Trial News
Simply Wall Street ·
- Expert Publication On PWS Treatment Could Be A Game Changer For Neurocrine Biosciences (NBIX)
Yahoo Finance ·
- NEUROCRINE BIOSCIENCES INC (NBIX) Stock Chart
ChartMill ·
- Neurocrine Biosciences, Inc. Estimates – NASDAQ:NBIX
TradingView ·
- Neurocrine Biosciences (NBIX) Starts Phase 2 Alzheimer’s Trial
Yahoo Finance ·
Neurocrine Biosciences Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $2.86B | $2.36B | $1.89B | $1.49B |
| Net income | $478.6M | $341.3M | $249.7M | $154.5M |
| Diluted EPS | $4.67 | $3.29 | $2.47 | $1.56 |
| Total assets (year end) | $4.63B | $3.72B | $3.25B | $2.37B |
| Cash and equivalents (year end) | $713.0M | $233.0M | $251.1M | $262.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Neurocrine Biosciences Inc
- Ticker
- NBIX (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 914475
Frequently asked questions
What exchange is Neurocrine Biosciences Inc listed on?
Neurocrine Biosciences Inc trades on the Nasdaq under the ticker symbol NBIX.
What industry is Neurocrine Biosciences Inc in?
Neurocrine Biosciences Inc is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Neurocrine Biosciences Inc headquartered?
Neurocrine Biosciences Inc's business address on file with the SEC is in San Diego, CA.
When does Neurocrine Biosciences Inc's fiscal year end?
Neurocrine Biosciences Inc's fiscal year ends on December 31.
How much revenue did Neurocrine Biosciences Inc report?
Neurocrine Biosciences Inc reported $2.86B in revenue for calendar year 2025, according to its SEC filings.